12/2010 - DrÅ¾avni zavod za intelektualno vlasniÅ¡tvo

More documents

Recommendations

Info

3554 HR - Patenti - Hrvatski glasnik intelektualnog vlasništva 17, 2010, 12, 3477 – 3584Y je cijano, nitro, C 1 -C4-alkil, C 1 -C 4 -haloalkil, metoksi ili metiltio;p je 0 ili 1;R 1 je vodik, halogen, C 1 -C 4 -alkil ili C 1 -C 4 -haloalkil;R 2 je vodik, metil ili halogen;R 3 je vodik, metil ili etil;W je kisik ili sumpor.Patent sadrži još 11 patentnih zahtjeva.(51) MKP (10) HR P20100614 T1C07D 279/20 (2006.01)A61K 31/5415 (2006.01)A61P 25/28 (2006.01)(11) P20100614(46) 31.12.2010.(21) P20100614T (22) 12.11.2010.(86) PCT/GB20070 01103 28.03.2007.(96) EP 07732164.4 28.03.2007.(87) WO2007110627, 04.10.2007.(97) EP 2013191, 14.01.2009. 200903, En(97) EP 2013191, 18.08.2010. 201033, En(31) 786690 P (32) 29.03.2006.(33) US(54) SOLI 3,7-DIAMINO-10H-FENOTIAZINA I NJIHOVA UPORABA3,7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE(73) Wista Laboratories Ltd., 51 Ayer Rajah Crescent No. 07-01/02,139948 Singapore, SG(72) Claude Michel Wischik, WisTa Laboratories Ltd. Institute of MedicalSciences Forresterhill, Aberdeen AB25 2ZD, Scotland, GBJanet Elizabeth Rickard, WisTa Laboratories Ltd. Institute ofMedical Sciences Forresterhill, Aberdeen, AB25 2ZD, Scotland, GBCharles Robert Harrington, WisTa Laboratories Ltd. Institute ofMedical Sciences Forresterhill, Aberdeen, AB25 2ZD, Scotland, GBDavid Horsley, WisTa Laboratories Ltd. Institute of MedicalSciences Forresterhill, Aberdeen, AB25 2ZD, Scotland, GBJohn Mervyn David Storey, WisTa Laboratories Ltd. Department ofChemistry Meston Walk, Old Aberdeen, AB24 3UE, Scotland, GBColin Marshall, WisTa Laboratories Ltd. Department of ChemistryMeston Walk, Old Aberdeen, AB24 3UE, Scotland, GBJames Peter Sinclair, WisTa Laboratories Ltd. Department ofChemistry Meston Walk, Old Aberdeen, AB24 3UE, Scotland, GBThomas Craven Baddeley, WisTa Laboratories Ltd. Department ofChemistry Meston Walk, Old Aberdeen, AB24 3UE, Scotland, GB(74) CPZ - CENTAR ZA PATENTE d.d., Zagreb, HR(57) Spoj, naznačen time, da je odabran od spojeva sljedeće formule injihovih farmaceutski prihvatljivih soli, solvata i hidrata:PYRIMIDINE DERIVATIVES USED AS PI-3 KINASE INHIBITORS( 73) Novartis AG, Lichtstrasse 35, 4056 Basel, CH(72) Matthew Burger, C/O NOVARTIS VACCINES AND DIAGNOSTICSINC. P.O. Box 8097, Emeryville, CA 94662-8097, USZhi-jie Ni, C/O NOVARTIS VACCINES AND DIAGNOSTICS INC.P.O. Box 8097, Emeryville, CA 94662-8097, USSabina Pecchi, C/O NOVARTIS VACCINES AND DIAGNOSTICSINC. P.O. Box 8097, Emeryville, CA 94662-8097, USGordana Atallah, C/O NOVARTIS VACCINES AND DIAGNOSTICSINC. P.O. Box 8097, Emeryville, CA 94662-8097, USSarah Bartulis, C/O NOVARTIS VACCINES AND DIAGNOSTICSINC. P.O. Box 8097, Emeryville, CA 94662-8097, USKelly Frazier, C/O NOVARTIS VACCINES AND DIAGNOSTICSINC. P.O. Box 8097, Emeryville, CA 94662-8097, USAaron Smith, C/O NOVARTIS VACCINES AND DIAGNOSTICSINC. P.O. Box 8097, Emeryville, CA 94662-8097, USJoelle Verhagen, C/O NOVARTIS VACCINES AND DIAGNOSTICSINC. P.O. Box 8097, Emeryville, CA 94662-8097, USYanchen Zhang, C/O NOVARTIS VACCINES AND DIAGNOSTICSINC. P.O. Box 8097, Emeryville, CA 94662-8097, USAllan Wagman, C/O NOVARTIS VACCINES AND DIAGNOSTICSINC. P.O. Box 8097, Emeryville, CA 94662-8097, USSimon Ng, C/O NOVARTIS VACCINES AND DIAGNOSTICS INC.P.O. Box 8097, Emeryville, CA 94662-8097, USKeith Pfister, C/O NOVARTIS VACCINES AND DIAGNOSTICSINC. P.O. Box 8097, Emeryville, CA 94662-8097, USDaniel Poon, C/O NOVARTIS VACCINES AND DIAGNOSTICSINC. P.O. Box 8097, Emeryville, CA 94662-8097, USAlicia Louie, C/O NOVARTIS VACCINES AND DIAGNOSTICS INC.P.O. Box 8097, Emeryville, CA 94662-8097, USTeresa Pick, C/O NOVARTIS VACCINES AND DIAGNOSTICSINC. P.O. Box 8097, Emeryville, CA 94662-8097, USPaul Barsanti, C/O NOVARTIS VACCINES AND DIAGNOSTICSINC. P.O. Box 8097, Emeryville, CA 94662-8097, USEdwin Iwanowicz, C/O NOVARTIS VACCINES ANDDIAGNOSTICS INC. P.O. Box 8097, Emeryville, CA 94662-8097,USWendy Fantl, C/O NOVARTIS VACCINES AND DIAGNOSTICSINC. P.O. Box 8097, Emeryville, CA 94662-8097, USThomas Hendrickson, C/O NOVARTIS VACCINES ANDDIAGNOSTICS INC. P.O. Box 8097, Emeryville, CA 94662-8097,USMark Knapp, C/O NOVARTIS VACCINES AND DIAGNOSTICSINC. P.O. Box 8097, Emeryville, CA 94662-8097, USHanne Meritt, C/O NOVARTIS VACCINES AND DIAGNOSTICSINC. P.O. Box 8097, Emeryville, CA 94662-8097, USCharles Voliva, C/O NOVARTIS VACCINES AND DIAGNOSTICSINC. P.O. Box 8097, Emeryville, CA 94662-8097, USMarion Wiesmann, C/O NOVARTIS VACCINES ANDDIAGNOSTICS INC. P.O. Box 8097, Emeryville, CA 94662-8097,USXiahua Xin, C/O NOVARTIS VACCINES AND DIAGNOSTICS INC.P.O. Box 8097, Emeryville, CA 94662-8097, US(74) CPZ - CENTAR ZA PATENTE d.d., Zagreb, HR(57) Spoj, naznačen time, da ima formulu I:gdje jesvaki od R 1 i R 9 neovisno odabran od -H, C 1-4 alkila, C 2-4 alkenila, ihalogeniranog C 1-4 alkila;svaki od R 3NA i R 3NB neovisno odabran od -H, C 1-4 alkila, C 2-4 alkenila, ihalogeniranog C 1-4 alkila;svaki od R 7NA i R 7NB neovisno odabran od -H, C 1-4 alkila, C 2-4 alkenila, ihalogeniranog C 1-4 alkila;svaki od HX 1 i HX 2 neovisno protična kiselina.Patent sadrži još 37 patentnih zahtjeva.(51) MKPC07D 401/04 (2006.01)(10) HR P20100603 T1C07D 401/14 (2006.01)C07D 405/12 (2006.01)C07D 405/14 (2006.01)C07D 417/12 (2006.01)A61K 31/506 (2006.01)A61P 35/00 (2006.01)(11) P20100603(46) 31.12.2010.(21) P20100603T (22) 09.11.2010.(86)(96)PCT/US20070 01708 22.01.2007.EP 07716906.8 22.01.2007.(87) WO2007084786, 26.07.2007.(97)(97)EP 1984350, 29.10.2008. 200844, EnEP 1984350, 18.08.2010. 201033, En(31) 760789 P (32) 20.01.2006.(33) US(54) DERIVATI PIRIMIDINA KOJI SE KORIS TE KAO INHIBITORI PI-3KINAZEili njegov stereoizomer, tautomer ili farmaceutski prihvatljiva sol, gdje Wje CR W ili N, gdje RWje odabran iz skupine koja sadrživodik,cijano,halogen,metil,trifluorometil,sulfonamid;R 1 je odabran iz skupine koja sadrživodik,cijano,nitro,halogen,supstituirani i nesupstituirani alkil,supstituirani i nesupstituirani alkenil,supstituirani i nesupstituirani alkinil,supstituirani i nesupstituirani aril,supstituirani i nesupstituirani heteroaril,ISSN 1847-3024
HR - Patenti - Hrvatski glasnik intelektualnog vlasništva 17, 2010, 12, 3477 – 3584 3555supstituirani i nesupstituirani heterociklil,supstituirani i nesupstituirani cikloalkil,-COR 1a ,-CO 2 R 1a ,-CONR 1a R1b,-NR 1a R 1b ,-NR 1a COR 1b ,-NR 1a SO 2 R1b,-OCOR 1a ,-OR 1a ,-SR 1a ,-SOR 1a ,-SO 2 R 1a , i-SO 2 NR 1a R 1b ,gdje R 1a i R 1b su neovisno odabrani iz skupine koja sadrživodik,supstituirani ili nesupstituirani alkil,supstituirani i nesupstituirani aril,supstituirani i nesupstituirani heteroaril,supstituirani i nesupstituirani heterociklil, isupstituirani i nesupstituirani cikloalkil;R 2 je odabran iz skupine koja sadrživodik,cijano,nitro,halogen,hidroksi,amino,supstituirani i nesupstituirani alkil,-COR 2a , i-NR 2a COR 2b ,gdje R 2a i R 2b su neovisno odabrani iz skupine koja sadrživodik, isupstituirani ili nesupstituirani alkil;R 3 je odabran iz skupine koja sadrživodik,cijano,nitro,halogen,supstituirani i nesupstituirani alkil,supstituirani i nesupstituirani alkenil,supstituirani i nesupstituirani alkinil,supstituirani i nesupstituirani aril,supstituirani i nesupstituirani heteroaril,supstituirani i nesupstituirani heterociklil,supstituirani i nesupstituirani cikloalkil,-COR 3a ,-NR 3a R 3b ,-NR 3a COR3b,-NR 3a SO 2 R3b,-OR 3a ,-SR 3a ,-SOR 3a ,-SO 2 R 3a , i-SO 2 NR 3a R 3b ,gdje R 3a i R 3b su neovisno odabrani iz skupine koja sadrživodik,supstituirani ili nesupstituirani alkil,supstituirani i nesupstituirani aril,supstituirani i nesupstituirani heteroaril,supstituirani i nesupstituirani heterociklil, isupstituirani i nesupstituirani cikloalkil;iR 4 je odabran iz skupine koja sadrživodik, ihalogen.Patent sadrži još 52 patentna zahtjeva.(51) MKP (10) HR P20100620 T1C07D 401/12 (2006.01)C07D 239/94 (2006.01)C07D 211/16 (2006.01)(11) P20100620(46) 31.12.2010.(21) P20100620T(22) 16.11.2010.(96)(97)(97)EP 09152654.1 27.09.2006.EP 2053048, 29.04.2009. 200918, EnEP 2053048, 15.09.2010. 201037, En(31) 0519879 (32) 30.09.2005.(33) GB(62) 06794582.4 ; 27.09.2006.(54) KEMIJSKI IN SITU POSTUPAK SULFONIRANJACHEMICAL IN SITU SULPHONATING PROCESS(73) AstraZeneca AB, , 151 85 Södertälje, SE(72) Jörgen Blixt, AstraZeneca R&D Södertälje, 431 85 Södertälje, SEMichael David Golden, AstraZeneca Charter Way, Macclesfield,Cheshire SK10 2NA, GBPhilip John Hogan, AstraZeneca Charter Way Macclesfield,Cheshire SK10 2NA, GBDavid Michael Glanville Martin, AstraZeneca Charter WayMacclesfield, Cheshire SK10 2NA, GBFrancis Joseph Montgomery, AstraZeneca Charter Way,Macclesfield, Cheshire SK10 2NA, GBZakariya Patel, AstraZeneca R&D Charnwood Bakewell Road,Loughborough, Leicestershire LE11 5RH, GBJohn David Pittman, AstraZeneca Charter Way, Macclesfield,Cheshire SK10 2NA, GBGeorge Joseph Sependa, AstraZeneca, Charter Way, Macclesfield,Cheshire SK10 2NA, GBChristopher John Squire, AstraZeneca Charter Way, Macclesfield,Cheshire SK10 4TG, GBNicholas Cartwright Alexander Wright, AstraZeneca, Charter Way,Macclesfield, Cheshire SK10 2NA, GB(74) PRODUCTA d.o.o., Zagreb, HR(57) Postupak za dobivanje spoja formule IIa:naznačen time da R je pogodan sulfonatni ester;iz (C1-C6)alkil-4-piperidinkarboksilatnog spoja prema formuli III:koji postupak sadrži slijedeće korake:(a) reakciju (C1-C6)alkil-4-piperidinkarboksilatnog spoja prema formuliIII sa di-terc-butil dikarbonatom u prisutnosti toluena ili ksilena koji tvoreprvu mješavinu koja sadrži toluen ili ksilen, terc-butanol i spoj premaformuli IV:(b) većinskog uklanjanja terc-butanola iz prve mješavine;(c) reakcije spoja prema formuli IV sa pogodnim sredstvom zaredukciju in situ u prisutnosti toluena ili ksilena koji tvore drugu mješavinukoja sadrži toluen, redukcijske nus-produkte uključujući alkoholne nusproduktei spoj prema formuli V:(d) većinskog uklanjanja alkoholnih nus-produkataiz druge mješavine; i(e) reakcije spoja prema formuli V sa pogodnim sredstvom zasulfoniranje in situ koji tvore sulfonatni ester u prisutnosti pogodne baze itoluena koji tvore spoj prema formuli IIa.Patent sadrži još 7 patentnih zahtjeva.(51) MKP (10) HR P20100604 T1C07D 403/04 (2006.01)C07D 253/06 (2006.01)C07D 453/02 (2006.01)C07D 405/04 (2006.01)C07D 409/04 (2006.01)ISSN 1847-3024
Page 1 and 2:
ISSN 1847-3024HRVATSKIGLASNIKINTELE
Page 3 and 4:
HR - Sadržaj - Hrvatski glasnik in
Page 5 and 6:
HR - Dvoslovne oznake - Hrvatski gl
Page 7:
Službene obavijestii tekstovi
Page 10 and 11:
3472 HR - Službene obavijesti - Hr
Page 12 and 13:
3474 HR - Službene obavijesti - Hr
Page 15:
PATENTIPATENTIPROŠIRENI EUROPSKI P
Page 18 and 19:
Objava prijava patenataObjavljujemo
Page 20 and 21:
3482 HR - Patenti - Hrvatski glasni
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 31 and 32:
Priznati patenti/konsenzualni paten
Page 33 and 34:
HR - Patenti - Hrvatski glasnik int
Page 35 and 36:
HR - Patenti - Hrvatski glasnik int
Page 37:
Objavakonsenzualnih patenataObjavlj
Page 40 and 41:
Page 42 and 43: 3504 HR - Patenti - Hrvatski glasni
Page 47: Promjene u Registruprijava patenata
Page 51: Prestanak vrijednostipatenata/konse
Page 55: Ispravci objavljenihpodatakaObjava
Page 59: PROŠIRENI EUROPSKIPATENTI
Page 62 and 63: Objava zahtjeva zaproširenje europ
Page 83 and 84: Prošireni europskipatentiObjava pr
Page 85 and 86: HR - Patenti - Hrvatski glasnik int
Page 91: HR - Patenti - Hrvatski glasnik int
Page 113 and 114: Europski patentiObjava europskih pa
Page 123: ŽigoviPRIJAVE ZA REGISTRACIJU ŽIG
Page 126 and 127: Objava prijava žigovaObjavljujemo
Page 128 and 129: 3590 HR - Žigovi - Hrvatski glasni
Page 142 and 143:
3604 HR - Žigovi - Hrvatski glasni
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150:
Page 153 and 154:
HR - Žigovi - Hrvatski glasnik int
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237:
Informacije o međunarodnimregistra
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 257 and 258:
Registrirani žigoviObjava žigovaK
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Page 323:
Produženje vrijednostiregistracija
Page 326 and 327:
Page 328 and 329:
Page 331 and 332:
Page 333 and 334:
Page 335:
Page 339 and 340:
Registracijaindustrijskoga dizajnaO
Page 341 and 342:
HR - Industrijska obličja/dizajn -
Page 343 and 344:
Page 345 and 346:
Page 347 and 348:
Page 349 and 350:
Page 351 and 352:
Page 353 and 354:
Page 355 and 356:
Page 357 and 358:
Page 359 and 360:
Page 361 and 362:
Page 363 and 364:
Page 365:
Page 369 and 370:
Page 371:
Prestanak vrijednosti priznatih pra
Page 375 and 376:
Informacije o međunarodnimregistra
Page 377 and 378:
Page 379 and 380:
Page 381 and 382:
Page 383:
Page 387:
HR - Oznake zemljopisnog podrijetla
Page 391:
HR - Hrvatski glasnik intelektualno
Page 395 and 396:
HR - Informacijski proizvodi i uslu
Page 397 and 398:
Page 399 and 400:
Page 401 and 402:
Page 403 and 404:
Page 405:
Referentneinformacije
Page 408:
3870HR - Popis zastupnika registrir
show all

12/2010 - DrÅ¾avni zavod za intelektualno vlasniÅ¡tvo

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?